Home Tags United States

Tag: United States

Combustible and electronic tobacco and marijuana products in hip-hop music videos

10/15/18--Combustible and electronic tobacco and marijuana use frequently occurred in popular hip-hop music videos from 2013 to 2017. The genre’s broad appeal, use of branded products by influential artists, and rise of electronic product and marijuana use may contribute to a growing public health concern of tobacco and marijuana use. Read

Legalized marijuana linked to a sharp rise in car crashes

10/18/18--There has been an increase by up to 6 percent in the number of highway crashes in four of the states where the recreational use of marijuana has been legalized, according to a pair of new studies. According to David Harkey, president of the Insurance Institute for Highway Safety’s Highway Loss Data Institute, the new reports do not prove there’s a direct risk caused by the use of marijuana among motorists, but they raise caution flags. Read 

Marijuana can help treat symptoms from multiple sclerosis, study finds

10/16/18--Multiple sclerosis (MS) could be yet another illness that could benefit from medical marijuana, according to new research. A study published in the journal JAMA Network Open found that “cannabinoids produce a limited and mild reduction of subjective spasticity, pain, and bladder dysfunction in patients with MS.” Read

Bill Weld: Former governor, now marijuana hype man

10/19/18--As a featured speaker at the Cannabis World Congress and Business Exposition in Boston, Bill Weld, former US attorney and governor of Massachusetts, appeared to be a hype man for Acreage Holdings. Weld actually supported marijuana for medical use as governor in the early 1990s, long before that policy had the widespread support of Americans. He also strongly endorsed the STATES Act, a bill that would repeal the federal prohibition of marijuana and allow states to set their own policies on the drug. Read

States with legal marijuana see rise in car crashes, studies find

10/19/18--Car crashes were up as much as 6 percent in states where the recreational use of marijuana has been legalized. According to research from the Insurance Institute for Highway Safety and the Highway Loss Data Institute, the frequency of collision claims filed to insurers were higher in four states where marijuana is legal: Colorado, Nevada, Oregon, and Washington. Read

Study shows higher rate of stroke among pot smokers

10/19/18--A new study ties marijuana to a raised risk for stroke. The risk for any stroke could increase by 15 percent and it could jump 29 percent for an ischemic stroke -- the most common kind, said lead investigator Dr. Krupa Patel, a research physician at Avalon University School of Medicine in Willemstad, Curacao. In the study, Patel and her colleagues found that among more than 2.3 million American recreational marijuana users who were hospitalized, the risk of stroke rose, compared with people who didn't use the drug. Read

Marijuana caused more damage to teens’ brains than alcohol, study finds

10/6/18--Marijuana use may pose a greater risk to the developing brains of teenagers than alcohol consumption, according to a new study  this week. The analysis, published Wednesday in the American Journal of Psychiatry, found that cannabis had greater short and long-term consequences than alcohol on four key components of teens' memory. The finding greatly surprised researchers. Read

What is marijuana kief and what can you do with it?

10/6/18--In short, marijuana kief is when tiny bulbs are separated from the plant's buds. Kief has been sold at dispensaries in Oregon on a more regular basis as the industry has continued to evolve, and it is also a key ingredient in tarantula joints, which involves kief being stuck to the outside of a joint with a marijuana concentrate serving as a bonding agent to keep the kief in place. Kief costs more than the flower, and it is extremely potent. Read

Canopy Growth and 4 other cannabis stocks that look good here

10/6/18--Timothy Collins of Real Money identifies 5 marijuana stocks that offer some diversification or unique features in the legal-weed space: GW Pharma, Canopy Growth, KushCo Holdings, Pyxus International, and CannaRoyalty. Read

From Willie to Whoopi, big names are getting behind the booming business of legal weed

9/27/18--As marijuana's popularity has increased, so has the number of celeb-branded pot products available in legal weed states. Some of them come from performers whose careers are already synonymous with marijuana, while others include mainstream stars who have leveraged their celeb status to get involved in medicinal marijuana-based projects. Read

Teens who’ve tried marijuana have used it in more than one form

9/28/18--Most teens who've tried marijuana have used the drug in more than one form, including products that are smoked, eaten, or vaped, new USC research shows. The study, published Friday in JAMA Network Open, raises concerns about adolescent health amid a booming marijuana market that touts sleekly packaged products claiming an array of health benefits. Read

Marijuana stock GW Pharmaceuticals nabs DEA Schedule V

9/27/18--The Drug Enforcement Agency (DEA) has awarded GW Pharmaceuticals' epilepsy drug, Epidiolex, Schedule V status, its least restrictive classification. The decision clears the way for GW Pharmaceuticals to begin offering the only CBD oil that's cleared by the DEA for use nationwide, and it puts the company on a path to disrupt how doctors treat patients who fail to respond to existing anti-epilepsy medications. Read

Constellation Brands execs will join Canopy Growth Board; Ontario marijuana laws unveiled

9/27/18--Two senior executives of Corona parent Constellation Brands will become directors of Canopy Growth after the Canadian marijuana producer's shareholders approved the beer-and-wine giant's $4 billion investment in the company. Additionally, the government of Ontario proposed rules that it said would create a "tightly regulated" marketplace for brick-and-mortar cannabis shops in the area. Read

High Times parent hustles to lure cannabis investors; here’s what you need to know

9/13/18--High Times Holding Corp., the parent company of the iconic marijuana culture magazine High Times, is looking to attract a large number of small investors as the publication works to go public, bolster its brand, and shore up a balance sheet mired in debt. Read

Federal chokehold on marijuana stymies studies on epilepsy, autism

9/11/18--In an editorial published in Spectrum, Shaun Hussain, director of the Infantile Spasms Program at the University of California, Los Angeles Mattel Children’s Hospital, addresses the cumbersome regulations discouraging many talented and motivated researchers from investigating the potential value of marijuana. Hussain openly expresses his views about marijuana containing 100 mostly unexplored chemicals (known collectively as cannabinoids), any one of which could aid the treatment of not just epilepsy and autism but any number of conditions. Read

4 niche marijuana stocks with massive market share

9/11/18--Marijuana stocks offering competitive advantages might prove attractive to investors. Throughout the industry, there are four such niche stocks that bring massive market share potential to the table: CannaRoyalty, Kush Bottles, GW Pharmaceuticals, and Innovative Industrial Properties. Read

Why the adult cannabis market could kill its medical counterpart

9/11/18--As more states continue to legalize recreational marijuana, speculation among industry pundits is that this could be the precursor to a major slowdown, if not death knell, for the medical marijuana industry. According to estimates by leading cannabis researchers ArcView Market Research in partnership with BDS Analytics, the latest revenue projections for the U.S. medical marijuana industry in 2018 is $4.3 billion versus $6.7 billion for adult use. Last year, medical racked up $5.9 billion while adult use snagged $2.6 billion. Read

Alcohol companies are seeing green in weed

9/11/18--As alcohol consumption around the world keeps falling, big distillers and brewers are putting their money into marijuana-infused, non-alcoholic cocktails. A string of deals between alcohol companies and marijuana companies illustrate the next big thing in beverages. Read

Marijuana use among young adults is at an all-time high, study finds

9/11/18--The National Institute on Drug Abuse recently released the results of its latest study, which examined trends on substance use among non-college and college young adults. More than 13 percent of young adults not in college reported using marijuana daily or near daily, which is the highest level ever among the group. As a result, NIDA said daily marijuana use is now three times as high among non-college young adults as among college students. Read

Marijuana comes to your coffee and candy—but is it legal?

9/12/18--Companies are selling a growing number of products that contain cannabidiol, or CBD, a chemical found in hemp. It’s being added to everything from gumdrops to beverages, as marketers claim benefits such as pain relief and stress reduction. Read

Anheuser-Busch heir shuns beer for push into Colorado marijuana

9/12/18--Adolphus Busch V, the 27-year-old great-great-grandson of the beer magnate Adolphus Busch, has launched a line of disposable marijuana vape pens, under the brand ABV Cannabis. The ABV vape pens are now in about two dozen stores. Busch decided to focus on the product because of growing popularity among marijuana users who want to avoid smoking. Read

Longtime tobacco supplier sees the future in marijuana

9/12/18--Alliance One International Inc. is the latest company pivoting to pot. With a valuation just north of $215 million, the North Carolina-based company is banking on the Canadian market to drive growth as tobacco cigarette smoking rates stagnate around the globe. The move comes as investors are pouring billions of dollars into the burgeoning industry, catapulting the value of marijuana stocks. Read

Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control

9/12/18--There has been a global decline in tobacco consumption that, if continued, will negatively impact the tobacco industry’s profits. This decline led the industry to invent and market new products, including heated tobacco products (HTP). HTP are an extension of the industry’s strategies to undermine government’s tobacco regulatory efforts as they are being promoted as part of the solution for the tobacco epidemic. Read

Comparing medical and recreational marijuana use among employees

9/4/18-- As policies and laws regarding marijuana use rapidly change, concerns have arisen over employees’ use of marijuana, for both medical and recreational purposes. While extant workplace research has not distinguished between types of marijuana users, other studies have found that those who use marijuana for medical purposes are clinically and socio-demographically different from non-medical users. Read

Why all sides in Congress can get behind Rep. Gabbard’s new cannabis legislation

7/25/18--Tulsi Gabbard (D-Hawaii) and Carlos Curbelo (R-Fla.) introduced the Marijuana Data Collection Act. The legislation itself takes no position on cannabis reform and instead, seeks to encourage research on existing and future state legalization programs so that policymakers can better understand the impact of those state laws. Gabbard’s bill takes a step that more people in Congress should consider: using data to inform policy. Read

New partners in weed startup: Jimmy Buffett and Wrigley Scion

9/11/18--Singer Jimmy Buffett and billionaire William “Beau” Wrigley Jr. are getting behind a U.S. marijuana startup, joining other companies betting on the increasingly crowded marijuana industry. Mr. Buffett will license his Coral Reefer brand to Surterra Holdings Inc. for a line of cannabis products including vape pens, gel caps, edibles, and lotions. Read

The marijuana stock that Wall Street likes the most

9/9/18--Currently, four pure-play marijuana stocks are listed on U.S. stock exchanges, Scotts Miracle-Gro, Canopy Growth Corporation, Cronos Group, and Tilray. According to The Motley Fool writer Keith Speights, Tilray, at least for now, ranks as the marijuana stock that Wall Street likes the most. Tilray is attracting investors' attention because of the potential that it could be the next to land a major deal -- perhaps with Diageo, another big beverage company reportedly looking for a marijuana partner. Read

These three cannabis stocks have been hijacked by traders

9/9/18--Three stocks, Canopy Growth, Cronos Group, and Tilray, have rallied sharply since August 14th. These three companies share a common trait in that they are all listed on the NASDAQ or the NYSE. This listing status has attracted traders in the U.S. who have avoided the sector. According to Cannabis industry analyst Alan Brockstein, traders have pushed these three stocks much higher than their peers that don't trade on a major U.S. exchange. Read

Cities defiant after Justice Department’s threat on ‘supervised injection sites’

9/4/18--Cities seeking to open sites where illegal drug users are monitored to prevent overdoses responded defiantly to a Justice Department threat to take “swift and aggressive action” against that approach to the nationwide opioid epidemic. Read

Inside the weird and wild crusade for clean pot

3/1/18--Figuring out what the rules should be to prevent impurities from contaminating pot is nearly impossible. There are no national standards like there are for food crops. “And unfortunately, pretty much all of the marijuana in the United States is drenched in harmful chemicals,” according to Rolling Stone reporter Amanda Chicago Lewis. “But let’s just say that if you like pot, you have absolutely exposed yourself to chemicals that can damage your central nervous system, mess with your hormones and give you cancer. Read

Fight drug abuse, don’t subsidize it

8/27/18--According to Rod J. Rosenstein, deputy attorney general of the United States, Americans struggling with addiction need treatment and reduced access to deadly drugs. They do not need a taxpayer-sponsored haven to shoot up. Advocates euphemistically call them “safe injection sites,” but Rosenstein believes they are very dangerous and would only make the opioid crisis worse. Read

Report warns of ‘serious risk’ to Peace Corps from drug use by volunteers

8/24/18--The Peace Corps has a drug problem related to an increasingly outdated view of marijuana, but significant enough to the agency’s Office of Inspector General that it warns of a “serious risk to the integrity and reputation of the Peace Corps as well as the health and safety of Volunteers.” Read

Institutional investors currently buzzing on marijuana stocks

8/27/18--Many marijuana stocks experienced significant stock price hikes recently, with notable gains coming last week, and there’s anticipation of even more institutional investors buying into the cannabis industry. For a better sense of what types of investors could be driving the most recent and future market shifts, Pot Network provides an overview of who is currently investing in, or is planning to invest in, a major cannabis stock. Read

Relationships between state laws legalizing marijuana for medical use and college students’ use of marijuana/other drugs

8/28/18--A study published in the Journal of Student Affairs Research and Practice examined the relationship between medicalized marijuana laws and student utilization rates, perceptions, and experiences. Participants were students in 37 states attending institutions of higher education. Students who went to college in states that legalized marijuana for medical use were more likely to use marijuana and experience academic and health consequences than their counterparts who did not. Read

Marijuana use among drivers killed in crashes doubled from 2007 to 2015

8/16/18--NHTSA, an organization with a mission to save lives, prevent injuries, and reduce economic costs due to road traffic crashes through education, research, safety standards, and enforcement reports marijuana use among drivers killed in crashes doubled from 2007 to 2015. The organization also states that if you feel different, you drive different. Read

Snapshot: About one in four young adults use marijuana

8/15/18--While 13 percent of Americans say they "regularly" or "occasionally" use or smoke marijuana, the rate is significantly higher among young adults ages 18 to 29 and is higher in the West than in other regions of the country. Marijuana is most popular among young adults -- about one in four (24 percent) adults in this age group report regularly or occasionally using it. This is on par with an average 22 percent of 18- to 29-year-olds across three surveys from 2015 to 2017 who answered "yes" when asked whether they do, or do not, "smoke marijuana." Read

WeedMD signs cannabis supply agreement with Nova Scotia liquor corporation

8/27/18--WeedMD announces that it has entered into a purchase agreement with the Nova Scotia Liquor Corporation (“NSLC”) to supply its branded cannabis products for the adult-use cannabis market in Nova Scotia. Read

Soured CBD deal highlights need for ‘persnickety’ due diligence

8/23/18--A tantalizing innovation in the CBD market has turned into a nasty contract dispute that spans the globe. Bomi Joseph, a California plant breeder, is suing CBD Naturals, a company that has been associated with Canadian CBD manufacturer Isodiol. Isodiol once held distribution rights to Joseph’s self-proclaimed innovation – a cannabidiol product derived from a hops variant. Read

GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress

8/7/18--GW Pharmaceuticals, the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the third quarter, in addition to addressing the significance of FDA approval of Epidiolex®. Read

Teens who vape or use hookah are more likely to use marijuana later, study finds

8/6/18--Teens who used e-cigarettes and hookah were up to four times more likely to use marijuana later, according to a study published Monday in the journal Pediatrics. The researchers found that the students who had tried e-cigarettes when they were freshmen had a more than three-fold greater likelihood of ever using marijuana and using marijuana in the past 30 days than students who hadn't tried e-cigs. Read

Adolescent e-cigarette, hookah, and conventional cigarette use and subsequent marijuana use

8/6/18--A study examining whether adolescent electronic cigarette (e-cigarette), hookah, or combustible cigarette use is associated with initiating and currently using marijuana as well as using both tobacco and marijuana concurrently concludes that the association between tobacco use and subsequent marijuana use across adolescence extends to multiple tobacco products. Read

The impact of medically supervised injection centres on drug-related harms

9/1/18--Medically Supervised Injection Centres (MSICs), legally-sanctioned facilities where users can consume pre-obtained drugs under medical supervision, had a significant, but small, positive effect on outcomes based on the fixed effect analysis and no effect based on random effect analysis, according to a meta-analysis conducted by Tom May, Trevor Bennett, and Katy Holloway of the Centre for Criminology, University of South Wales. Furthermore, MSICs were found to have no effect on overdose mortality or syringe/equipment sharing. Read

App helps legal cannabis market find goods, real estate, customers

8/7/18--Nugl is a metadata search engine and online directory for the legal marijuana industry, with a database that, according to its own business descriptions can “display listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.” The expanded Nugl platform, announced today to cover all of North America, offers profiles of cannabis companies and professional services related to the business, an organized marketing website for B-to-B (business-to-business) applications, and related consumer uses. Read

Schizophrenia, cannabis use, and alcohol abuse are just several disorders that are related to accelerated brain aging

8/21/18--In the largest known brain imaging study, scientists from Amen Clinics (Costa Mesa, CA), Google, John's Hopkins University, University of California, Los Angeles, and the University of California, San Francisco evaluated 62,454 brain SPECT (single photon emission computed tomography) scans of more than 30,000 individuals from 9 months old to 105 years of age to investigate factors that accelerate brain aging. SPECT tomography evaluates regional cerebral blood flow in the brain that is reduced in various disorders. Read

California Commissioner named chair of new NAIC cannabis committee

8/9/18--The National Association of Insurance Commissioners has named California Insurance Commissioner Dave Jones chair of its new Cannabis Insurance Working Group. Jones previously chaired the NAIC’s Sharing Economy Working Group, which developed a template for insurance coverage for ridesharing and home sharing. Read

David Crosby talks marijuana, his upcoming weed brand & Joni Mitchell

8/9/18--David Crosby, the founding member of The Byrds and Crosby, Stills, Nash & Young is seeking licensing opportunities with a cannabis brand under the suggested moniker “Mighty Croz.” Crosby says now is the right time for him to formally enter the business of pot. Read

Cowboys’ David Irving defends marijuana use, bashes NFL in Instagram rant

8/18/18--Cowboys defensive lineman David Irving took to Instagram on Friday to open up more on his issues with substance abuse and even claimed he's been medicated in every game he's been in. Irving candidly ranted about why he doesn't think using marijuana is wrong and blamed the NFL's policy, saying "The NFL laws on weed are and we all know it." Read

GW Pharmaceuticals slaps price tag on cannabis-based epilepsy drug

8/9/18--GW Pharmaceuticals has revealed the price of its cannabis-based epilepsy drug Epidiolex. The medication, which is expected to be available by early fall, will have a $32,500 price tag. Epidiolex was approved in June by the U.S. Food and Drug Administration (FDA) for the treatment of two rare forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome. The company said the $32,500 price tag is in line with other branded antiepileptic drugs used to treat these conditions. Read

Risk-taking, antisocial teens 5 times more likely to die young

8/10/18--Adolescents with serious conduct and substance use problems are five times more likely to die prematurely than their peers, with roughly one in 20 dying by their 30s, according to new CU Boulder research. The study, published today in the journal Addiction, also suggests that while drug and alcohol use among adolescents draws more attention, antisocial behavior -- including rule-breaking tendencies -- may be a more powerful predictor of early mortality. Read

College students may face pressures from opioid epidemic’s secondary effects

8/11/18--About one in five college students reported in a survey that they knew someone who was addicted to pain medications, and nearly a third said they knew somebody who overdosed on painkillers or heroin, according to a team of undergraduate Penn State Lehigh Valley researchers. "This secondary exposure to opioid abuse may shine a light on the collateral damage that is often left out of the current debate about the epidemic," said Jennifer Parker, associate professor of sociology, Penn State Lehigh Valley. Read

‘I don’t think I look like a stoner’: the women changing the face of the cannabis industry

8/12/18--As weed’s legal status loosens across the US, the way cannabis is being marketed, sold, and celebrated is evolving. An industry that has been dominated by men is finding a female voice in consumers and new business owners. There are now yoga retreats, workouts, day spas, parties, conferences – all for women who like weed. As the weed market continues to grow, women are shifting perceptions of the drug and its users. Stoner stereotypes are being knocked back and women are talking openly about the place weed has in their lives. Read

Journal Times editorial: Pot referendums could sway election

8/12/18--This coming November, City of Racine residents will have the chance to vote in an advisory referendum on the question of whether marijuana should be legal for medicinal and/or recreational use, as well as what the potential revenue should be used for. Keeping in mind the fact that the marijuana referendums could sway the election, the poses the question: Is this the right time? Would April be a better time? Read

Legal Weed: How Republicans learned to love marijuana

8/16/18--For decades, marijuana legalization was a nonstarter in Washington, and particularly in Republican politics. The party considered cannabis a dangerous gateway drug, but as state experimentation with legalization grew, media coverage of marijuana’s supposed health benefits increased, and public opinion and demographics shifted, Republicans—some of whom had touted their hard-line stances as unalterable—began to soften. Read

Bruce Linton discusses deploying CA$5 billion, Canopy’s commitment to international growth

8/16/18--Canopy Growth, a Canadian medical marijuana giant, is taking a massive 5 billion Canadian dollar ($3.8 billion) investment and going all in on worldwide medical and recreational cannabis business opportunities, the company’s CEO, Bruce Linton, said during an exclusive, wide-ranging question-and-answer session in Toronto. Constellation Brands – which owns, distributes, and markets 100 beer, wine, and spirits brands, announced this record-setting investment in Canopy Growth, the largest involving a marijuana company to date. Read

Corona beer giant puts $3.8 billion bet on US love of cannabis

8/16/18--Constellation Brands Inc., which for seven decades has made its money off beer, wine and whiskey, sees its future in a marijuana leaf. In the biggest (legal) cannabis deal, the Victor, New York-based beverage company will spend about $3.8 billion to boost its stake in Canadian grower Canopy Growth Corp., betting legalization will gain traction around the world and especially in the U.S. Read

Believe it or not, medical marijuana sales could fall

8/12/18--Based on the continued expansion of countries and states that allow legal medical marijuana, it may be assumed that global medical marijuana spending will keep on growing in 2018 like it has in previous years. However, Arcview Market Research and BDS Analytics project that global medical marijuana spending will drop by more than 19% year over year in 2018. Yet, medical marijuana sales are expected to increase again, and the growth rate over the next four years should be nearly as impressive as the period between 2014 and 2017. Read

Can Article V federally legalize cannabis?

8/12/18--Article V, a legal precedent set by America’s founding fathers, permits two-thirds of the states to call for a Convention of States to put forth proposed amendments to the Constitution.  If the proposed amendment is passed by three-fourths of the states as they are comprised in Congress, then the Constitution will be amended. Article V has been considered to be the latest legal avenue to pursue to potentially challenge the current, federal administration’s predilection for prohibition. However, according to cannabis law expert, Bob Carp, pursuing an Article V legal strategy would be an exercise in futility. Apparently, Article V is not the best precedent for challenging federal prohibition. Read

FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder

8/6/18--The U.S. Food and Drug Administration issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT) drugs for the treatment of opioid use disorder (OUD). New draft guidance issued outlines new ways for drug developers to consider measuring and demonstrating the effectiveness and benefits of new or existing MAT products. Furthermore, this new draft guidance is part of the FDA’s ongoing commitment to promote more widespread development, access to and adoption of MAT. Read

Another major beer company is now part of the marijuana craze

8/12/18--Heineken is another major beer company angling for its piece of the cannabis-infused beverage pie. With cannabis flourishing in the U.S., even as the federal government holds firm on its Schedule I classification, Heineken sees an opportunity. Roughly two weeks ago, on July 30, Heineken launched a cannabis-only beverage in a handful of dispensaries in California through its wholly owned Lagunitas craft-brewing brand. Designed to taste like beer, but containing no alcohol, Heineken hopes that its Hi-Fi Hops beverage catches on quickly with consumers. Read

I replaced my entire beauty routine with only CBD products

8/14/18--Glamour magazine writer Lindsey Unterberger engaged in a weeklong CBD experiment to replace all of her beauty products with their marijuana counterparts. For the sake of experimentation, she vowed to use only beauty products made with either CBD or hemp. Unterberger reported that switching to all CBD beauty products didn't drastically change her life or her skin, but she did rethink those largely off-base stereotypes she made about them, and she can safely say she now gets the buzz around CBD beauty. Read